Congress Should Halt OMB’s Rewrite Of Circular A-4 Guidance On Regulatory Cost-Benefit Analysis

As federal spending and regulation surge, the White House is proposing changes behind the scenes to redefine many such interventionist pursuits as "net beneficial."